Since 2017, the IBSA Group has adopted an anti-corruption guideline with the aim of building a Governance increasingly based on principles and rules to be followed to prevent corrupt conduct of any kind.
“Building solid governance means adopting a structured system of rules that allows us on the one hand to operate according to criteria of maximum efficiency and, on the other, to ensure the highest standards of transparency, legality, traceability and reliability”, commented Elisabetta Racca, Head of Legal Affairs, IBSA.
A responsible Governance can also be a useful tool to become more efficient. Improving performances, also in organisational terms, is part of a path that IBSA Farmaceutici has undertaken for some time now, by optimising the management of its processes, providing itself with adequate skills, improving quality parameters over time and bringing out a culture based on the utmost professionalism and shared by the whole company. This path also includes the application of management systems compliant with ISO standards targeted at continuous improvement.
“Ethical Governance is an important issue to be promoted in order to improve the involvement and contribution of all IBSA Farmaceutici collaborators”, explained Francesco Sturniolo, Legal, Compliance & Anti-Corruption Specialist, IBSA Farmaceutici. “It is important to be aware of the fact that all corporate processes, without exception, are potentially subject to risks to be assessed and managed, and everyone has the duty to make their own contribution. All corporate processes are critical for the company, both for the maintenance of its activities and for its market reputation”.
